002900.SZShenzhen
Harbin Medisan Pharmaceutical Co., Ltd.
¥10.05
ListedSep 25, 2017
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryChina
Employees-
State-| CityHarbin| AddressThe middle part of Beijing Road| Phone86 451 8560 8888
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China. The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropisetron hydrochloride and glucose injection, gabexate mesylate for injection, bismuth potassium citrate granules, pantoprazole sodium for injection, ambroxol hydrochloride and glucose injection, asarone for injection, paracetamol and tramadol hydrochloride tablets, rifamycin sodium for injection, lornoxicam for injection, vecuronium bromide for injection, and vitamin c for injection. It also provides medical devices and cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
0.0
?
Div. Rate
¥0.20
?
Div. Yield
1.94%
?
Payout Ratio
500.00%
?
Max Consec. Div. Years
8 years
?
Longest Consec. Div.
8 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.53
?
Div. Growth Rate
50.00%
?
Score
74

Dividend History

Historical dividend payments by ex-dividend date.

May 29, 2025
¥ 0.2000
Jun 5, 2024
¥ 0.2000
May 31, 2023
¥ 0.1000
Jun 13, 2022
¥ 0.3200
Jul 5, 2021
¥ 0.0800
Jun 30, 2020
¥ 0.2800
Jun 4, 2019
¥ 0.6500
Jun 13, 2018
¥ 0.3333

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!